Antiplatelet efficacy and specificity of DMP728, a novel platelet GPIIb/IIIa receptor antagonist

Cardiology (Switzerland)

Volumn 83, Issue 5-6, 1993, Pages 374-382

  Mousa, Shaker A ^a   Bozarth, Jeff M ^a   Forsythe, Mark S ^a   Lorelli, William ^a   Thoolen, Martin J ^a   Ramachandran, N ^a   Jackson, Sharon ^a   de Grado, William ^a   Reilly, Thomas M ^a  

^a DUPONT COMPANY   (United States)

Author keywords

Adhesion molecules; Antiplatelet; DMP728; Fibrinogen; GPIIb IIIa; Integrins; Platelet

Indexed keywords

ANTITHROMBOCYTIC AGENT; CYCLIC [(D 2 AMINOBUTYRATE N METHYL L ARGINYL GLYCYL L ASPARTYL) 3 AMINOMETHYL BENZOIC ACID] METHANE SULFONATE; CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE; FIBRINOGEN; FIBRINOGEN RECEPTOR; THROMBOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING COMPETITION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMPEDANCE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; THROMBOCYTE AGGREGATION;

ANIMAL; BLOOD PLATELETS; FIBRINOGEN; HUMAN; IN VITRO; INTEGRINS; MESYLATES; PEPTIDES, CYCLIC; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, CYTOADHESIN; RECEPTORS, VITRONECTIN;

EID: 0027749470     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000175994     Document Type: Article

References (20)

1. Ashby B, Daniel JL, Smith JB: Mechanisms of platelet activation and inhibition. Platelet Health Dis 1990;4:1-26.
2. Saltiel E, Ward A: Ticlopidine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in platelet-dependent disease states. Drugs 1987;34:222-262.
3. Golino P, Ashton JH, Glas-Greenwalt P, et al: Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with t-PA in a canine preparation of coronary thrombosis. Circulation 1988;77: 678-684.
4. Walenga JM, Pifarra R, Farced J: Recombinant hirudin as an antithrombotic agent. Drugs Future 1990;15:267-270.
5. Pytela R, Pierschbacher MS, Ginsberg MH, Plow EF, Ruoslahti E: Platelet membrane glycoprotein IIb/IIIa: Member of a family of RGD specific adhesion receptors. Science 1986;231:1559-1562.
6. Philips D, et al: GPIIb/IIIa: The responsive integrin. Cell 1991;65:359-362.
7. D’Souza SE, Ginsberg MH, Burke TA, Plow EF: The ligand binding site of the platelet integrin receptor GPIIb-IIIa is proximal to the second calcium binding domain of its a subunit. J Biol Chim 1990;265:3440-3446.
8. Ruggeri ZM, Houghton RA, Russel SR, Zimmerman TS: Inhibition of platelet function with synthetic peptide designed to be high affinity antagonist of fibrinogen binding to platelets. Proc Natl Acad Sci USA 1986;83:5708-5712.
9. Pierschbac MD, Lu Keman DS, Cheng S, et al: New composition comprising cyclic peptide for treating-preventing thrombosis and vascular graft occlusion etc. WO 9115515, 1991.
10. Allen MC, Kane PD, Wade R: New peptide platelet aggregation inhibitors for treatment of stroke and myocardial infarction. EP452257, EP91810219, 1991.
11. Nicholson NS, Panzer-Knodle SG, Salyers AK, et al: In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent. Thromb Res 1991;62:567-578.
12. Yasuda T, Gold HK, Fallon JT, et al: Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest 1988;81:1284-1291.
13. Mousa SA, Bozarth J, Forsythe M, Pease L, Reilly TM: Role of platelet GPIIb/IIIa receptors in the modulation of platelet plasminogen activator inhibitor type-1. Life Sci 1993; in press.
14. Chen CS, Hawiger J: Reactivity of synthetic peptide analogs of adhesive proteins in regard to the interaction of human endothelial cells with extracellular matrix. Blood 1991;77:2200-2206.
15. Rubenstein MD, Wall RT, Bain DS, Harrison DC: Platelet activation in clinical coronary artery disease and spasm. Am Heart J 1981;102:363-367.
16. Smitherman TC, Milam M, Woo J, Willerson JT, Frankel EP: Elevated beta thromboglobulin in peripheral venous blood of patients with acute myocardial ischemia: Direct evidence for enhanced platelet reactivity in vivo. Am J Cardiol 1981;48:395-402.
17. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA: Platelet activation in unstable coronary disease. N Engl J Med 1986;315:983-989.
18. Fuster V, Steele PM, Chesebro JH: Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J Am Coll Cardiol 1985;5:175B-184B.
19. Travis J: Biotech gets a grip on cell adhesion: Frontier in biotechnology. Science 1993;260:906-908.
20. Mousa SA, Mayo MC, Bozarth JM, Forsythe MS, Reilly TM: Antiplatelet effects of thrombin inhibitors versus GPIIb/IIIa receptor antagonists: Comparative kinetic and mechanistic analysis. Tromb Haemost 1993;69:2792.